Table 2 Clinical and cytokine variables at 1-year follow-up, comparison between AP- and AP + groups.
From: Cytokine changes in clinical high risk for psychosis population following antipsychotic medication
Variables | AP- | AP + | Comparison | |
|---|---|---|---|---|
t/Z/χ2 | P value | |||
Converters(n(%)) | 5(17.9) | 16(26.7) | χ2 = 0.815 | 0.367 |
GAF-v2 [Mean(S.D.)] | 71.1(9.3) | 68.1(10.1) | t = 1.354 | 0.179 |
SIPS-P-v2 [Mean(S.D.)] | 3.7(2.7) | 4.7(4.6) | t = −0.995 | 0.322 |
SIPS-N-v2 [Mean(S.D.)] | 7.6(6.3) | 11.0(7.0) | t = −2.123 | 0.037 |
SIPS-D-v2 [Mean(S.D.)] | 2.8(3.1) | 4.7(4.1) | t = −2.105 | 0.038 |
SIPS-G-v2 [Mean(S.D.)] | 6.0(3.1) | 6.0(3.3) | t = −0.094 | 0.925 |
SIPS-Total-v2 [Mean(S.D.)] | 20.1(13.2) | 26.3(16,3) | t = −1.745 | 0.085 |
VEGF-v2 [Median(IQR)] [Mean(S.D.)] | 89.6(57.7–134.4) 105.4(73.0) | 73.3(35.2–100.3) 79.4(51.9) | Z = −1.822 | 0.068 |
TNF-α-v2 [Median(IQR)] [Mean(S.D.)] | 10.8(9.7–12.3) 10.7(2.2) | 10.4(9.1–12.4) 10.7(2.9) | Z = −0.381 | 0.703 |
IL-8-v2 [Median(IQR)] [Mean(S.D.)] | 9.0(6.6–13.3) 11.1(5.8) | 8.6(6.0–11.9) 9.4(4.8) | Z = −1.111 | 0.267 |
IL-6-v2 [Median(IQR)] [Mean(S.D.)] | 1.0(0.7–1.4) 1.2(0.7) | 1.0(0.7–1.4) 1.2(0.6) | Z = −0.036 | 0.971 |
IL-1β-v2 [Median(IQR)] [Mean(S.D.)] | 0.4(0.3–0.6) 0.5(0.3) | 0.3(0.2–0.4) 0.3(0.2) | Z = −1.967 | 0.049 |
IL-10-v2 [Median(IQR)] [Mean(S.D.)] | 0.3(0.1–0.7) 0.4(0.5) | 0.3(0.1–0.5) 0.3(0.3) | Z = −0.725 | 0.468 |
GM-CSF-v2 [Median(IQR)] [Mean(S.D.)] | 2.8(1.9–3.5) 2.9(1.2) | 2.5(1.9–3.0) 2.5(0.9) | Z = -1.411 | 0.158 |
